Read the latest news and advances by the Beatty Laboratory
Bringing cancer immunotherapy to pancreatic cancer
JAN 2019 The Abramson Cancer Center to host symposium from April 11-12, 2019 on Immunology and Immunotherapy for Pancreatic Cancer.
Preclinical models for safety assessment of IO drugs
SEPT 2018 FDA-AACR Workshop on non-clinical models for safety assessment of immuno-oncology products. Gregory Beatty MD PhD speaks on the role of syngeneic mouse models.
Purplestride Philadelphia 2018
SEPT 2018 Gregory Beatty, MD PhD named honorary co-chair for the 2018 Purplestride Philadelphia held on Nov 3, 2018.
Innate immune agonists induce immunity against a “cold” tumor
MAR 2018 Combining two innate immune agonists stimulates productive anti-tumor immunity against an immunologically “cold” tumor without requirement for immune checkpoint blockade.
The underpinnings of liver metastasis
APR 2017 Through a SU2C Innovation Research Grant the Beatty Laboratory is investigating how cancer spreads to the liver and the impact of the liver on cancer therapy.
The Beatty Laboratory is part of the Perelman School of Medicine at the University of Pennsylvania.